Table 2 Baseline characteristics of patients
From: Drug-resistant epilepsy in Saudi Arabia: prevalence, predictive factors, and treatment outcomes
Characteristics | Epilepsy status (%) | p-value | ||
|---|---|---|---|---|
Responsive | DRE | Undefined | ||
Age | ||||
> 18 | 9 (64.3) | 2 (14.3) | 3 (21.4) | 0.073 |
18–28 | 82 (64.6) | 27 (21.3) | 18 (14.2) | |
29–39 | 64 (62.7) | 33 (32.4) | 5 (4.9) | |
40–50 | 26 (57.8) | 14 (31.1) | 5 (11.1) | |
> 50 | 42 (67.7) | 18 (29.0) | 2 (3.2) | |
Gender | ||||
Male | 116 (62.4) | 52 (28.0) | 18 (9.7) | 0.8529 |
Female | 107 (65.2) | 42 (25.6) | 15 (9.1) | |
Approximate Number of Years Since the Diagnosis | ||||
Less than 5 | 47 (59.5) | 15 (19.0) | 17 (21.5) | 0.002 |
Between 5 and 10 | 77 (68.8) | 29 (25.9) | 6 (5.4) | |
Between 11 and 15 | 31 (73.8) | 10 (23.8) | 1 (2.4) | |
Between 16 and 20 | 29 (67.4) | 11 (25.6) | 3 (7.0) | |
More than 20 | 11 (26.8) | 25 (61.0) | 5 (12.2) | |
Unknown | 16 (76.2) | 4 (19.0) | 1 (4.8) | |
Etiology | ||||
Genetic and presumed genetic | 156 (67.2) | 55 (23.7) | 21 (9.1) | < 0.001 |
Structural | 63 (65.6) | 30 (31.2) | 3 (3.1) | |
Infection | 2 (20.0) | 7 (70.0) | 1 (10.0) | |
Unknown | 2 (16.7) | 2 (16.7) | 8 (66.7) | |
Type of Seizure | ||||
Focal | 110 (62.9) | 52 (29.7) | 13 (7.4) | 0.005 |
Generalized | 101 (70.6) | 28 (19.6) | 14 (9.8) | |
Combined | 12 (37.5) | 14 (43.8) | 6 (18.8) | |
Emergency department visit due to seizure | ||||
Yes | 61 (44.9) | 65 (47.8) | 10 (7.4) | < 0.001 |
No | 162 (75.7) | 29 (13.6) | 23 (10.7) | |
Therapy type | ||||
Monotherapy | 195 (79.3) | 39 (15.9) | 12 (4.9) | < 0.001 |
Polytherapy | 28 (26.9) | 55 (52.9) | 21 (20.2) | |